Policy· August 8, 2026 · 14 min readEU Joint Clinical Assessments under the HTA Regulation: 2026 market access guideUnder Regulation (EU) 2021/2282, EU Joint Clinical Assessments are live for oncology. We analyze the 16-procedure pipeline, PICO...By Ran Chen#EU HTA#Joint Clinical Assessment#Market Access
Deals· August 8, 2026 · 15 min readServier's $2.5B Day One deal: tovorafenib (Ojemda) & first EU JCA completionWe analyze Servier's $2.5B Day One buyout, the clinical profile of tovorafenib (Ojemda) in pediatric glioma, and its landmark first...By Ran Chen#Servier#Day One#Tovorafenib